Genprex Inc (GNPX)

[Zack2000]

“Roche Holding AG, the Swiss drug giant that said it would pay $4.3 billion in cash to buy Philadelphia-based gene therapy developer Spark Therapeutics in February, has posted another delay.”

“Commenting on this important step forward, Severin Schwan, CEO of Roche, said, “We are excited about this important milestone because we believe that together, Roche and Spark will be able to significantly improve the lives of patients through innovative gene therapies. This acquisition supports our long-lasting commitment to bringing transformational therapies and innovative approaches to people around the world with serious diseases.” “


“Gene therapy is an experimental technique that uses genes to treat or prevent disease. In the future, this technique may allow doctors to treat a disorder by inserting a gene into a patient's cells instead of using drugs or surgery. “